78 157

Cited 22 times in

Eosinophil activation and novel mediators in the aspirin-induced nasal response in AERD.

Authors
Choi, GS; Kim, JH; Shin, YS; Ye, YM; Kim, SH; Park, HS
Citation
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 43(7):730-740, 2013
Journal Title
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
ISSN
0954-78941365-2222
Abstract
BACKGROUND: Eosinophil activation is the key feature of upper and lower airway inflammation in aspirin-exacerbated respiratory disease (AERD).



OBJECTIVE: To investigate the mechanism of eosinophil activation and identify novel inflammatory mediators using proteomics.



METHODS: Thirty-two asthmatic subjects were enrolled: 18 AERD patients who showed positive responses to the lysine-aspirin nasal provocation test (L-ASA NPT) and 14 aspirin-tolerant asthma (ATA) patients who showed negative responses to the L-ASA NPT (control group). Nasal lavage fluid (NLF) was collected before (baseline), at 10, 30 and 60 min (early response), and at 3 h (late response) after the L-ASA NPT. Eosinophil cationic protein (ECP) and cysteinyl leucotriene (CysLT) levels were measured using an ImmunoCAP system and ELISA respectively. To identify proteins involved in AERD, comparative proteomics was applied using NLFs collected before and after L-ASA NPTs in AERD patients. The clinical relevance of identified novel proteins was evaluated by ELISA using NLFs from the AERD and ATA groups.



RESULTS: Eosinophil cationic protein and CysLT levels both increased significantly during the early response in AERD. ECP levels increased until the late response in AERD, while CysLT levels were not significantly increased during the late response. Proteomic analysis showed up-regulation of apolipoprotein A1 (ApoA1), α2-macroglobulin (α2M) and ceruloplasmin (CP), with significant increases in NLF of AERD patients, which was significantly higher in AERD patients with chronic rhinosinusitis. Significant correlations were noted between ECP and CysLT, ApoA1, α2M and CP levels during the early response in AERD patients.



CONCLUSION: Eosinophil activation occurred in early and late responses after L-ASA NPT in upper airway mucosa of AERD patients, where ApoA1, α2M and CP as well as CysLT may be involved in eosinophilic inflammation.
MeSH terms
AdultApolipoprotein A-I/metabolismAsthma, Aspirin-Induced/*metabolism/pathologyBiological Markers/metabolismCysteine/metabolismEosinophil Cationic Protein/*metabolismEosinophils/*metabolism/pathologyFemaleHumansInflammation/metabolism/pathologyInflammation Mediators/*metabolismLeukotrienes/metabolismMaleMiddle Aged*Nasal Lavage FluidNasal Provocation TestsProteomics/methodsRespiratory Mucosa/*metabolism/pathologyalpha-Macroglobulins/metabolism
DOI
10.1111/cea.12096
PMID
23786280
Appears in Collections:
Journal Papers > Research Organization > Regional Clinical Trial Center
Journal Papers > School of Medicine / Graduate School of Medicine > Allergy
AJOU Authors
신, 유섭예, 영민김, 승현박, 해심
Full Text Link
Files in This Item:
fulltext not available.txtDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse